DRRX

DRRX

USD

DURECT Corporation Common Stock

$1.910-0.020 (-1.036%)

Real-time Price

Healthcare
Drug Manufacturers - Specialty & Generic
United States

Price Chart

No chart data available

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$1.930

High

$1.910

Low

$1.910

Volume

N/A

Company Fundamentals

Market Cap

59.3M

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

Trading Stats

Avg Volume

1.36M

Exchange

NCM

Currency

USD

52-Week Range

Low $0.4801Current $1.910High $2.64

Related News

AccessWire

Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025

LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. , a global, diversified pharmaceutical company, and DURECT Corporation today announced that

View more
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBTX, PVBC, DRRX on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

View more
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBTX, PVBC, DRRX on Behalf of Shareholders
PR Newswire

DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health

DURECT Corporation (Nasdaq: DRRX) today announced financial results for the second quarter ended June 30, 2025 and provided an update on the...

View more
DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health